SeaStar Medical Holding Co. (NASDAQ:ICU – Get Free Report) saw a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 357,600 shares, an increase of 18.8% from the February 13th total of 300,900 shares. Approximately 4.2% of the shares of the company are sold short. Based on an average daily trading volume, of 421,900 shares, the days-to-cover ratio is presently 0.8 days.
Institutional Investors Weigh In On SeaStar Medical
A hedge fund recently raised its stake in SeaStar Medical stock. Geode Capital Management LLC increased its position in shares of SeaStar Medical Holding Co. (NASDAQ:ICU – Free Report) by 14.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 45,430 shares of the company’s stock after purchasing an additional 5,618 shares during the period. Geode Capital Management LLC owned approximately 1.02% of SeaStar Medical worth $88,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 1.69% of the company’s stock.
SeaStar Medical Stock Performance
Shares of ICU stock traded down $0.02 during midday trading on Thursday, hitting $2.08. 8,927 shares of the company were exchanged, compared to its average volume of 246,060. The firm has a market capitalization of $13.46 million, a P/E ratio of -0.18 and a beta of -0.97. SeaStar Medical has a 52 week low of $1.50 and a 52 week high of $22.00. The firm’s 50 day moving average price is $1.83 and its two-hundred day moving average price is $2.75.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.
Further Reading
- Five stocks we like better than SeaStar Medical
- What is the MACD Indicator and How to Use it in Your Trading
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Conference Calls and Individual Investors
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 5 Top Rated Dividend Stocks to Consider
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
